Consistent with our recent observation in a cohort of PAH patients and controls [4], plasma BMP9 and pBMP10 levels correlated closely, suggesting some degree of co-regulation, though the measured levels of pBMP10 were ten times greater than those for BMP9 (eFig. 1E). The gene discussed is GDF2; the disease is pulmonary arterial hypertension.